{"organizations": [], "uuid": "9ea882faced21653a6c7a913aca617513986835c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180122.html", "section_title": "Archive News &amp; Video for Monday, 22 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-valbiotis-announces-significant-ef/brief-valbiotis-announces-significant-effect-of-valediaon-intestinal-microbiota-idUSFWN1PH03A", "country": "US", "domain_rank": 408, "title": "BRIEF-Valbiotis Announces Significant Effect Of Valedia On Intestinal Microbiota", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.773, "site_type": "news", "published": "2018-01-22T15:31:00.000+02:00", "replies_count": 0, "uuid": "9ea882faced21653a6c7a913aca617513986835c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-valbiotis-announces-significant-ef/brief-valbiotis-announces-significant-effect-of-valediaon-intestinal-microbiota-idUSFWN1PH03A", "ord_in_thread": 0, "title": "BRIEF-Valbiotis Announces Significant Effect Of Valedia On Intestinal Microbiota", "locations": [], "entities": {"persons": [], "locations": [{"name": "valbiotis", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 22 (Reuters) - VALBIOTIS SAS:\n* VALBIOTIS ANNOUNCES A SIGNIFICANT EFFECT OF VALEDIA® ON INTESTINAL MICROBIOTA\n* VALEDIA(®) ACTS ON MICROBIOTA IMBALANCES ASSOCIATED WITH METABOLIC DISEASES (PRECLINICAL)\n* ADDITIONAL DATA STRENGTHENS VALUE OF VALEDIA FOR PREVENTING TYPE 2 DIABETES\n* VALBIOTIS CONTINUES ITS METAGENOMICS PROGRAM TO ASSESS HOW ITS PRODUCTS AFFECT MICROBIOTA Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-22T15:31:00.000+02:00", "crawled": "2018-01-23T18:12:52.011+02:00", "highlightTitle": ""}